Priser
Platform
Blog
Om os
Download
T14
Tianjin Pharmaceutical Da Re Tang Group Corp
Singapore Exchange
0

Om

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is a prominent entity in the pharmaceuticals industry, primarily focused on research, development, and manufacturing of traditional Chinese medicines and modern pharmaceuticals. As one of China's leading pharmaceutical companies, it maintains a robust portfolio that includes herbal medicine, chemical pharmaceuticals, and biotechnological products, catering to both domestic and international markets. The company's products are extensively used in therapeutic areas such as cardiovascular, respiratory, and metabolic health, reflecting its influence across various health-related sectors. Established in one of China's economic growth hubs, Tianjin, the corporation plays a crucial role in advancing medical health solutions aligned with traditional and contemporary scientific approaches. Its strategic importance in the pharmaceutical market is significant due to its comprehensive approach in addressing the health needs through innovation and adherence to China's rich medicinal heritage, thus impacting community health at large.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TIANJIN PHARMACEUTICAL DA RE TANG GROUP CORP MED ENDAVU: Køb Tianjin Pharmaceutical Da Re Tang Group Corp ($T14) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Tianjin Pharmaceutical Da Re Tang Group Corp, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerT14
Land
Kina
Antal medarbejdere3.890
Hjemmesidejydrt.com.cn
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,05USD
'21
0,08USD
'22
0,16USD
'23
0,18USD
'24
0,17USD
'25
0,35USD
'26
Ex-udbytte-dato30. jan. 2026
Udbytteafkast11,07%